Kalamazoo, Michigan, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL....
Provides Ortho RTI with worldwide rights to commercialize Buoy Suspension Fractional System in combination with Ortho-R Provides Ortho RTI with Hanuman Buoy Suspension Fractional System for all US clinical...
HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has sold over...
LOS ANGELES, Dec. 30, 2020 /PRNewswire/ - TheraCell Inc., a leading allograft solution company, today announced that it has completed the first surgical case using its TheraFuze DBF® Fiber Bullets™. This...
Implant Is First New Treatment for ACL Tears in 30+ Years; Enables Injured ACL to Heal Itself WESTBOROUGH, Massachusetts – December 17, 2020 – Miach Orthopaedics, Inc., a privately held company...
Adds proprietary technology platform and complementary products to grow Integra’s regenerative portfolio PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced...
Improves clinical performance in spine by adding unprecedented information to the AlphaInformatiX Platform Accelerates revenue growth through immediate access to EOS’ prestigious 380-unit installed base, which overlaps minimally with ATEC’s...
Northpond Ventures leads round New investors include Deerfield Management and Casdin Capital. All existing investors participated including The Blue Venture Fund, Echo Health Ventures and Section 32 Funds will...
SUNNYVALE, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify® Cervical Artificial Disc, today announced its first...
SILVER SPRING, Md., Dec. 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted marketing authorization—under the De Novo premarket review pathway—for an anterior cruciate ligament (ACL) implant, intended to serve...